108 related articles for article (PubMed ID: 839984)
1. Further studies on biological activities of new peptide fragments derived from high molecular weight kininogen: an enhancement of the vascular permeability increase of the fragments by prostaglandin E2.
Oh-ishi S; Tanaka K; Katori M; Han YN
Life Sci; 1977 Feb; 20(4):695-9. PubMed ID: 839984
[No Abstract] [Full Text] [Related]
2. Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E2 and arachidonic acid in rabbit skin.
Ikeda K; Tanaka K; Katori M
Prostaglandins; 1975 Nov; 10(5):747-58. PubMed ID: 1215537
[TBL] [Abstract][Full Text] [Related]
3. The effects of prostaglandin E1, bradykinin and histamine on canine synovial vascular permeability.
Grennan DM; Mitchel W; Miller W; Zeitlin IJ
Br J Pharmacol; 1977 Jun; 60(2):251-4. PubMed ID: 880434
[TBL] [Abstract][Full Text] [Related]
4. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
[TBL] [Abstract][Full Text] [Related]
5. Effect of forskolin on alterations of vascular permeability induced with bradykinin, prostaglandin E1, adenosine, histamine and carrageenin in rats.
Sugio K; Daly JW
Life Sci; 1983 Jul; 33(1):65-73. PubMed ID: 6683350
[TBL] [Abstract][Full Text] [Related]
6. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia).
Johnston MG; Hay JB; Movat HZ
Agents Actions; 1976 Nov; 6(6):705-11. PubMed ID: 1008016
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin and prostaglandin E1, E2 and F2alpha-induced macromolecular leakage in the hamster cheek pouch.
Svensjö E
Prostaglandins Med; 1978 Nov; 1(5):397-410. PubMed ID: 724817
[TBL] [Abstract][Full Text] [Related]
8. Estrogen induced changes in uterine sensitivity for the decidual cell reaction: interactions between prostaglandin E2 and histamine or bradykinin.
Power SG; Kennedy TG
Prostaglandins; 1982 Feb; 23(2):219-26. PubMed ID: 6952528
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin I2 as a potentiator of acute inflammation in rats.
Komoriya K; Ohmori H; Azuma A; Kurozumi S; Hashimoto Y; Nicolaou KC; Barnette WE; Magolda RL
Prostaglandins; 1978 Apr; 15(4):557-64. PubMed ID: 353901
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: Prostaglandin D1 inhibits the increase in vascular permeability in rat skin produced by prostaglandin E1, E2 and D2.
Flower RJ; Kingston WP
Br J Pharmacol; 1975 Oct; 55(2):239P-240P. PubMed ID: 1201383
[No Abstract] [Full Text] [Related]
11. Negligible potency of acetylcholine in increasing vascular permeability.
Kawana S; Katori M
Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):32-40. PubMed ID: 7416887
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of histamine-induced microvascular permeability by prostaglandin E2 in rat mesentery.
Ohya Y; Guth PH
Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):331-48. PubMed ID: 3869839
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of histamine and bradykinin on capillary permeability.
Mizuta K
Mie Med J; 1970 Sep; 20(2):157-66. PubMed ID: 5514314
[No Abstract] [Full Text] [Related]
14. [The mechanism of anti-vascular permeability of 2-(2-fluoro-4-biphenylyl) propionic acid(Flurbiprofen) (author's transl)].
Yamamoto S; Higuchi Y
Nihon Yakurigaku Zasshi; 1980 Jan; 76(1):45-9. PubMed ID: 7380361
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins as potentiators of increased vascular permeability in inflammation.
Williams TJ; Morley J
Nature; 1973 Nov; 246(5430):215-7. PubMed ID: 4271544
[No Abstract] [Full Text] [Related]
16. The effect of hyperemia on vascular permeability.
Kopaniak MM; Hay JB; Movat HZ
Microvasc Res; 1978 Jan; 15(1):77-82. PubMed ID: 634159
[No Abstract] [Full Text] [Related]
17. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
Imamura T; Dubin A; Moore W; Tanaka R; Travis J
Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4: a mediator of vascular permeability.
Bray MA; Cunningham FM; Ford-Hutchinson AW; Smith MJ
Br J Pharmacol; 1981 Mar; 72(3):483-6. PubMed ID: 6266567
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
Angle MJ; McManus LM; Pinckard RN
Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
[TBL] [Abstract][Full Text] [Related]
20. Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators.
Fantone JC; Kunkel SL; Ward PA; Zurier RB
J Immunol; 1980 Dec; 125(6):2591-6. PubMed ID: 7430639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
